Who
Emily M. Leproust
Chief Executive Officer
Company insider
Files Form 4 as: Chief Executive Officer, Twist Bioscience; Director, GeneDx Holdings.
In numbers
- Trades disclosed
- 506
- Buys
- 0
- Sells
- 110
- Bought
- $0
- Sold
- $265.6M
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 19 Nov 2018
- Last trade
- 5 Oct 2026
- Last filed
- 7 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 5 Oct 2026filed 7 Oct 2026 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Sold | $369K1,840 at $200.44 | filing |
| 5 Oct 2026filed 7 Oct 2026 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Sold | $97K481 at $201.26 | filing |
| 5 Oct 2026filed 7 Oct 2026 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Sold | $206K1,017 at $202.32 | filing |
| 5 Oct 2026filed 7 Oct 2026 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Sold | $88K432 at $203.61 | filing |
| 5 Oct 2026filed 7 Oct 2026 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Sold | $59K290 at $204.80 | filing |
| 5 Oct 2026filed 7 Oct 2026 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Sold | $61K297 at $205.78 | filing |
| 5 Oct 2026filed 7 Oct 2026 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Sold | $30K146 at $206.84 | filing |
| 5 Oct 2026filed 7 Oct 2026 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Sold | $9,33645 at $207.46 | filing |
| 2 Oct 2026filed 5 Oct 2026 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Sold | $8.6M45,736 at $188.88 | filing |
| 1 Oct 2026filed 5 Oct 2026 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Sold | $131K655 at $200.00 | filing |
| 24 Sep 2026filed 25 Sep 2026 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Sold | $435K2,485 at $175.23 | filing |
| 24 Sep 2026filed 25 Sep 2026 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Sold | $15K83 at $184.60 | filing |
| 24 Sep 2026filed 25 Sep 2026 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Sold | $167K945 at $176.39 | filing |
| 24 Sep 2026filed 25 Sep 2026 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Sold | $29K164 at $177.17 | filing |
| 24 Sep 2026filed 25 Sep 2026 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Sold | $59K330 at $178.67 | filing |
| 24 Sep 2026filed 25 Sep 2026 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Sold | $26K143 at $179.93 | filing |
| 24 Sep 2026filed 25 Sep 2026 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Sold | $93K515 at $180.39 | filing |
| 24 Sep 2026filed 25 Sep 2026 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Sold | $3,81021 at $181.45 | filing |
| 24 Sep 2026filed 25 Sep 2026 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Sold | $2,92016 at $182.50 | filing |
| 24 Sep 2026filed 25 Sep 2026 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Sold | $92K501 at $183.76 | filing |
The newest 500 lines are listed; the numbers count every line.
News
Twist Bioscience Corporation (TWST) Leads Polen's Small-Mid Growth Portfolio on Record Revenue and AI-Driven DemandTWST · insidermonkey.com · 23 Oct 2026Twist Bioscience (NASDAQ:TWST) Shares Climb 6.6% – Here's What HappenedTWST · dailypolitical.com · 23 Oct 2026Twist Bioscience (NASDAQ:TWST) versus Quanterix (NASDAQ:QTRX) Financial AnalysisTWST · tickerreport.com · 15 Oct 2026
0 headlines in the last 90 days name Emily M. Leproust; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.